Search - tctmd.com

Displaying 341 - 360 of 510

Sort: Relevancy | Date

Presentation TVT 2023

SavvyWire® to Facilitate Lifetime Patient Management and Case Efficiency with LV Pacing

Presenter: Jonathan Schwartz

June 09, 2023

Presentation TVT 2023

Sensor-Guided Solutions for Optimizing Outcomes without Compromise

Presenter: Philippe Genereux

June 09, 2023

Presentation TVT 2023

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

Presenter: Sachin Goel

June 08, 2023

Presentation TVT 2023

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Presentation TVT 2023

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Presenter: Joao Cavalcante

June 08, 2023

Presentation TVT 2023

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Presenter: Sachin Goel

June 08, 2023

Presentation TVT 2023

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Presenter: Eberhard Grube

June 08, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

Pre-recorded Case: Accurate Neo 2

Presenter: Ole De Backer

June 08, 2023

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Azeem Latib

June 08, 2023

Presentation TVT 2023

Pre-recorded Case: Navitor

Presenter: Ibrahim Sultan

June 08, 2023

Presentation TVT 2023

Highlighting the TAVR Access to Care Dilemma

Presenter: Larry Wood

June 08, 2023

Presentation TVT 2023

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Presenter: Amit Vora

June 08, 2023

Presentation TVT 2023

Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Presenter: Tamim Nazif

June 08, 2023

Presentation TVT 2023

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Presenter: Samir Kapadia

June 08, 2023

Presentation TVT 2023

Position 3: TAVR With a Supra-Annular Valve

Presenter: Rishi Puri

June 08, 2023

Presentation TVT 2023

Aortic Regurgitation and Time to TAVR in Trifecta Versus Non-Trifecta Bioprosthetic Valves

Presenter: Amr Abbas

June 08, 2023

Presentation TVT 2023

Position 2: TAVR With an Annular Valve

Presenter: Christine Chung

June 08, 2023

Advertisement

SavvyWire® to Facilitate Lifetime Patient Management and Case Efficiency with LV Pacing

Sensor-Guided Solutions for Optimizing Outcomes without Compromise

The Case for ‘Default OAC’ in Valve-in-Valve TAVR – Pros and Cons

Case Resolution: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What

SPOTLIGHT LECTURE: Show Me the Data! Is HALT After TAVR Associated With Clinical Events or Accelerated SVD?

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Case Presentation: A Patient With Recent TAVR, Receiving SAPT, and at 1 Month Has Elevated Gradient on Echo, and CT Shows HALT – Now What?

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Pre-recorded Case: Accurate Neo 2

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Pre-recorded Case: Navitor

Highlighting the TAVR Access to Care Dilemma

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection

Position 3: TAVR With a Supra-Annular Valve

Aortic Regurgitation and Time to TAVR in Trifecta Versus Non-Trifecta Bioprosthetic Valves

Position 2: TAVR With an Annular Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content